Xie H, Turner T, Wang M H, Singh R K, Siegal G P, Wells A
Department of Pathology, University of Alabama at Birmingham 35294-007, USA.
Clin Exp Metastasis. 1995 Nov;13(6):407-19. doi: 10.1007/BF00118180.
Prostate carcinomas often present an autocrine stimulatory loop in which the transformed cells both express the EGF receptor (EGFR) and produce activating ligands (TGF alpha and EGF forms). Up-regulated EGFR signalling has been correlated with tumor progression in other human neoplasia; however, the cell behaviour which is promoted remains undefined. To determine whether an EGFR-induced response contributes to cell invasiveness, we transduced DU-145 human prostate carcinoma cells with either a full-length (WT) or a mitogenically-active but motility-deficient truncated (c'973) EGFR. The DU-145 Parental and two transgene sublines all produced EGFR and TGF alpha, but the transduced WT and c'973 EGFR underwent autocrine downregulation to a lesser degree, with more receptor remaining intact. DU-145 cells transduced with WT EGFR transmigrated a human amniotic basement membrane matrix (Amgel) to a greater extent than did Parental DU-145 cells (175 +/- 22%). Cells expressing the c'973 EGFR invaded through the Amgel only to about two thirds the extent of the Parental cells (62 +/- 23%). A monoclonal antibody which prevents ligand-induced activation of EGFR decreased the invasiveness of WT-expressing cells by half and Parental cells by a fifth, but had little effect on the invasiveness of c'973-expressing cells; with the result that in the presence of antibody, all three cell lines transmigrated the Amgel to the same extent. The different levels of invasiveness between the three sublines were independent of cell proliferation. These findings demonstrated that EGFR-mediated signals increase tumor cell invasiveness and suggested that domains in the carboxy-terminus are required to signal invasiveness. As an initial investigation into the mechanisms underlying the EGFR-mediated enhanced invasiveness, we determined whether these cells presented different collagenolytic activity, as the major constituents of Amgel are collagen types I and IV. All three sublines secreted easily detectable levels of gelatin-directed proteases and TIMP-1, with WT cells secreting equivalent or lower levels of proteases. The proteolytic balance in these cells did not correlate with invasiveness. These data suggest that the TGF alpha-EGFR autocrine loop promotes invasiveness and that this is accomplished by signalling cell properties other than differential secretion of collagenolytic activity.
前列腺癌常常呈现出一种自分泌刺激环,其中转化细胞既表达表皮生长因子受体(EGFR),又产生激活配体(转化生长因子α和表皮生长因子形式)。在其他人类肿瘤中,上调的EGFR信号传导与肿瘤进展相关;然而,其促进的细胞行为仍不明确。为了确定EGFR诱导的反应是否有助于细胞侵袭,我们用全长(WT)或有丝分裂活性但运动缺陷的截短型(c'973)EGFR转导DU-145人前列腺癌细胞。DU-145亲本细胞系和两个转基因亚系均产生EGFR和转化生长因子α,但转导的WT和c'973 EGFR自分泌下调程度较小,更多的受体保持完整。用WT EGFR转导的DU-145细胞穿过人羊膜基底膜基质(Amgel)的迁移程度比亲本DU-145细胞更大(175±22%)。表达c'973 EGFR的细胞穿过Amgel的侵袭程度仅为亲本细胞的约三分之二(62±23%)。一种阻止配体诱导的EGFR激活的单克隆抗体使表达WT的细胞侵袭性降低一半,使亲本细胞侵袭性降低五分之一,但对表达c'973的细胞侵袭性影响很小;结果是在存在抗体的情况下,所有三种细胞系穿过Amgel的迁移程度相同。三个亚系之间不同程度的侵袭性与细胞增殖无关。这些发现表明EGFR介导的信号增加肿瘤细胞侵袭性,并提示羧基末端结构域是信号传导侵袭性所必需的。作为对EGFR介导的增强侵袭性潜在机制的初步研究,我们确定这些细胞是否呈现不同的胶原酶活性,因为Amgel的主要成分是I型和IV型胶原。所有三个亚系均分泌易于检测水平的明胶定向蛋白酶和金属蛋白酶组织抑制因子-1,WT细胞分泌的蛋白酶水平相当或更低。这些细胞中的蛋白水解平衡与侵袭性无关。这些数据表明转化生长因子α-EGFR自分泌环促进侵袭性,并且这是通过除胶原酶活性差异分泌之外的细胞特性信号传导来实现的。